Detailansicht
Contemporary Drug Synthesis
eBook - Wiley Series on Drug Synthesis
Li, Jie Jack/Sliskovic, Drago R/Roth, Bruce D et al
ISBN/EAN: 9780471686736
Umbreit-Nr.: 3685596
Sprache:
Englisch
Umfang: 240 S., 3.63 MB
Format in cm:
Einband:
Keine Angabe
Erschienen am 27.12.2004
Auflage: 1/2004
E-Book
Format: PDF
DRM: Adobe DRM
- Zusatztext
- An integrated and insightful look at successful drug synthesis in today's drug discovery market<p>The pharmaceutical industry is unquestionably vibrant today, with drug synthesis making a vital contribution. Whether in the early developmental stages of identifying and optimizing a lead, or the latter stages of process development and cost-effective scale-up, the ability to design elegant and economical synthetic routes is often a major factor in the eventual viability and commercial success of a drug.</p><p><i>Contemporary Drug Synthesis</i> examines how leading researchers and manufacturers have integrated chemistry, biology, pharmacokinetics, and a host of other disciplines in the creation and development of leading drugs.</p><p>Authored by four of the pharmaceutical industry's most respected scientists, this timely volume:</p><ul><li>Focuses on the processes that resulted in high-profile drugs including Lipitor, Celebrex, Viagra, Gleevec, Nexium, Claritin, and over a dozen others</li><li>Provides an in-depth introduction to each drug, followed by a detailed account of its synthesis</li><li>Organizes the drugs into fourteen therapeutic areas for clarity and ease of use</li></ul> Process chemists provide an essential bridge between chemistry and the marketplace, creating scientifically practical drug processes while never losing sight of the commercial viability of those processes.<i>Contemporary Drug Synthesis</i> meets the needs of a growing community of researchers in pharmaceutical research and development, and is both a useful guide for practicing pharmaceutical scientists and an excellent text for medicinal and organic chemistry students.
- Autorenportrait
- <b>JIE-JACK LI, PhD, DOUGLAS S. JOHNSON, PhD, DRAGO R. SLISKOVIC, PhD, AND BRUCE D. ROTH, PhD</b>, are all members of Pfizer Global Research and Development, and are among the most prominent scientists working in drug discovery today.